Real-time enrollment status for this neuroendocrine tumors clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT05724108 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Neuroendocrine Tumors |
| Phase | Clinical Trial |
| Target Enrollment | 94 participants |
| Active Locations | 25 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | February 27, 2026 (3 days ago) |
As of March 2, 2026: Clinical trial NCT05724108 is currently active_not_recruiting participants. This clinical trial study for neuroendocrine tumors is not currently accepting new participants at 25 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05724108 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 25 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05724108 was last updated 3 days ago (February 27, 2026). HelloStudys verifies this status automatically.